←Back to Expert Scholars
Translational Medicine / 转化医学Advanced Merkel Cell Carcinoma
Paul Nghiem
MD, PhD
🏢University of Washington / Fred Hutch🌐USA
Professor of Dermatology
72
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Paul Nghiem is a globally recognized leader in Merkel cell carcinoma research. He led pivotal trials establishing pembrolizumab and avelumab as frontline MCC immunotherapy. His lab investigates polyomavirus-specific T cell responses and novel immunotherapy combinations.
Share:
🧪Research Fields 研究领域
Merkel cell carcinoma
Polyomavirus
Immunotherapy
Translational research
T-cell responses
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Paul Nghiem 的研究动态
Follow Paul Nghiem's research updates
留下邮箱，当我们发布与 Paul Nghiem（University of Washington / Fred Hutch）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment